NHS approves prescribing Mounjaro, a diabetes drug, for obesity treatment in eligible patients.

The NHS has approved prescribing Mounjaro, a diabetes drug, to help fight obesity. Mounjaro, a glucagon-like peptide-1 (GLP-1) agonist, has been recommended by the National Institute for Health and Care Excellence (Nice) for patients with a body mass index (BMI) of 35 and at least one obesity-related condition. It is expected to be prescribed alongside a reduced-calorie diet and exercise.

June 04, 2024
6 Articles